Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 16 matching records.
16 results — page 1 of 1
- Level DLaboratory StudyEurope PMC
Brain-derived extracellular vesicles: A promising avenue for Parkinson's disease pathogenesis, diagnosis, and treatment
Laboratory Study on Neuroinflammation, published in Neural Regen Res (2026) — summary generated from the PubMed abstract.
- 2026
Neural Regen Res7 citations - Level DLaboratory StudyEurope PMC
The Use of Extracellular Vesicles as a Promising Therapeutic Approach for Pulmonary Diseases
Laboratory Study on Immune Modulation, published in Health Sci Rep (2025) — summary generated from the PubMed abstract.
- 2025
Health Sci Rep1 citations - Level DNarrative ReviewEurope PMC
Stem Cell-Derived Extracellular Vesicles: Promising Therapeutic Opportunities for Diabetic Wound Healing
Narrative Review on Diabetic Foot, Chronic Wound, published in Int J Nanomedicine (2024) — summary generated from the PubMed abstract.
- 2024
Int J Nanomedicine17 citations - Level DAnimal StudyEurope PMC
Macrophage-derived extracellular vesicles represent a promising endogenous iron-chelating therapy for iron overload and cardiac injury in myocardial infarction
Animal Study on Cardiovascular Disease, published in J Nanobiotechnology (2024) — summary generated from the PubMed abstract.
- 2024
J Nanobiotechnology12 citations - Level DAnimal StudyPubMed
Macrophage heterogeneity regulation by small extracellular vesicles from adipose-derived stem cells: A promising approach for treating chronic prostatitis/pelvic pain syndrome.
Animal Study on Chronic Inflammation, published in Biomater Adv (2024) — summary generated from the PubMed abstract.
- 2024
Biomater Adv5 citations - Level DNarrative ReviewEurope PMC
Mesenchymal Stem Cells and Their Extracellular Vesicles Are a Promising Alternative to Antibiotics for Treating Sepsis
Narrative Review on Chronic Inflammation, Immune Modulation, published in Bioengineering (Basel) (2024) — summary generated from the PubMed abstract.
- 2024
Bioengineering (Basel)7 citations - Level DLaboratory StudyPubMed
Mesenchymal stem cell-derived extracellular vesicles: A promising therapeutic strategy in diabetic osteoporosis.
Laboratory Study on Systemic / IV, published in World J Diabetes (2024) — summary generated from the PubMed abstract.
- 2024
World J Diabetes2 citations - Level DNarrative ReviewEurope PMC
Extracellular vesicles: Emerged as a promising strategy for regenerative medicine
Narrative Review, published in World J Stem Cells (2023) — summary generated from the PubMed abstract.
- 2023
World J Stem Cells11 citations - Level BClinical TrialEurope PMC
Advances of mesenchymal stem cells and their derived extracellular vesicles as a promising therapy for acute respiratory distress syndrome: from bench to clinic
Clinical Trial on Chronic Inflammation, published in Front Immunol (2023) — summary generated from the PubMed abstract.
- 2023
Front Immunol14 citations - Level DNarrative ReviewEurope PMC
Cell-free therapy based on extracellular vesicles: a promising therapeutic strategy for peripheral nerve injury
Narrative Review, published in Stem Cell Res Ther (2023) — summary generated from the PubMed abstract.
- 2023
Stem Cell Res Ther42 citations - Level DNarrative ReviewEurope PMC
Adipose Tissue-Derived Extracellular Vesicles: A Promising Biomarker and Therapeutic Strategy for Metabolic Disorders
Narrative Review on Systemic / IV, published in Stem Cells Int (2023) — summary generated from the PubMed abstract.
- 2023
Stem Cells Int16 citations - Level ASystematic ReviewEurope PMC
Dental stem cell-derived extracellular vesicles as promising therapeutic agents in the treatment of diseases
Systematic Review, published in Int J Oral Sci (2022) — summary generated from the PubMed abstract.
- 2022
Int J Oral Sci43 citations - Level DNarrative ReviewEurope PMC
Extracellular vesicles: a promising cell-free therapy for cartilage repair
Narrative Review on Cartilage Damage, published in Future Sci OA (2022) — summary generated from the PubMed abstract.
- 2022
Future Sci OA22 citations - Level DNarrative ReviewEurope PMC
Comprehensive insight into endothelial progenitor cell-derived extracellular vesicles as a promising candidate for disease treatment
Narrative Review on Acute Kidney Injury, published in Stem Cell Res Ther (2022) — summary generated from the PubMed abstract.
- 2022
Stem Cell Res Ther33 citations - Level DNarrative ReviewEurope PMC
Skin cell-derived extracellular vesicles: a promising therapeutic strategy for cutaneous injury
Narrative Review on Chronic Wound, Scar, published in Burns Trauma (2022) — summary generated from the PubMed abstract.
- 2022
Burns Trauma22 citations - Level DNarrative ReviewEurope PMC
Extracellular vesicles and amyotrophic lateral sclerosis: from misfolded protein vehicles to promising clinical biomarkers
Narrative Review on Neuroinflammation, published in Cell Mol Life Sci (2021) — summary generated from the PubMed abstract.
- 2021
Cell Mol Life Sci56 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406